This document provides information about tablets, including their definition, advantages, disadvantages and types. It discusses the main components of tablets, including active ingredients and excipients. It describes different types of tablets based on their route of administration and production process. The purposes and examples of various excipients like diluents, binders, disintegrants, lubricants and coloring agents are outlined. Granulation is introduced as a process to prevent segregation and improve flow of powder mixtures that are then compressed into tablets.
Hard gelatin capsules - a detailed studyTeny Thomas
The presentation involves a descriptive study on hard gelatin capsules which includes the production of the hard gelatin capsule shell, size of the capsules, capsule filling machines and the finishing techniques. The presentation also involves the special techniques of capsule formulation and the quality control tests of hard gelatin capsules
University Institute of Pharmaceutical Sciences is a flag bearer of excellence in Pharmaceutical education and research in the country. Here is another initiative to make study material available to everyone worldwide. Based on the new PCI guidelines and syllabus here we have a presentation dealing with the tablets and its excipients and Ideal properties of tablet and the methods and equipment for there for manufacturing.
Thank you for reading.
Hope it was of help to you.
UIPS,PU team
A detailed study on tablets, its classification, excipients, tablet granulation, methods of granulation, compression machines, equipment tooling and the problems that occur during the tablet manufacturing process. This presentation is based on the PCI syllabus for bpharm students of fifth semester.
Hard gelatin capsules - a detailed studyTeny Thomas
The presentation involves a descriptive study on hard gelatin capsules which includes the production of the hard gelatin capsule shell, size of the capsules, capsule filling machines and the finishing techniques. The presentation also involves the special techniques of capsule formulation and the quality control tests of hard gelatin capsules
University Institute of Pharmaceutical Sciences is a flag bearer of excellence in Pharmaceutical education and research in the country. Here is another initiative to make study material available to everyone worldwide. Based on the new PCI guidelines and syllabus here we have a presentation dealing with the tablets and its excipients and Ideal properties of tablet and the methods and equipment for there for manufacturing.
Thank you for reading.
Hope it was of help to you.
UIPS,PU team
A detailed study on tablets, its classification, excipients, tablet granulation, methods of granulation, compression machines, equipment tooling and the problems that occur during the tablet manufacturing process. This presentation is based on the PCI syllabus for bpharm students of fifth semester.
In this presentation I have tried to explain in detail about tablets, their different types, ingredients which are used to prepare them, and the procedure to prepare them as well. This presentation is very useful for pharmacy students.
Tablets: a.Introduction, ideal characteristics of tablets, Classification of tablets. Excipients, Formulation of tablets, granulation methods, compression and processing problems.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
2. Scope
Introduction
Advantages and disadvantages of
compressed tablets
Types of tablets
Tablet compression machine
Tableting methods
– Direct compression
3. Introduction
Tablet is defined as a compressed solid dosage form
containing medicaments with or without excipients.
Pharmaceutical tablets are solid, flat or biconvex
dishes, unit dosage form, prepared by compressing a
drugs or a mixture of drugs, with or without
diluents. They vary in shape and differ greatly in size
and weight, depending on amount of medicinal
substances and the intended mode of
administration. It is the most popular dosage form
and 70% of the total medicines are dispensed in the
form of Tablet. All medicaments are available in the
Tablet form except where it is difficult to formulate
or administer.
5. The advantages of the Tablet dosage form are:
1. They are unit dosage form and offer the greatest capabilities of all oral dosage form for the
greatest dose precision and the least content variability.
2. Cost is lowest of all oral dosage form.
3. Lighter and compact.
4. Easiest and cheapest to package and strip.
5. Easy to swallowing with least tendency for hang-up.
6. Sustained release product is possible by enteric coating.
7. Objectionable odour and bitter taste can be masked by coating technique.
8. Suitable for large scale production.
9. Greatest chemical and microbial stability over all oral dosage form.
10. Product identification is easy and rapid requiring no additional steps when employing an
embossed and/or monogrammed punch face.
6. Disadvantages of Tablet dosage form are:
1. Difficult to swallow in case of children and unconscious patients.
2. Some drugs resist compression into dense compacts, owing to amorphous nature,
lowdensity character.
3. Drugs with poor wetting, slow dissolution properties, optimum absorption high in GIT
may be difficult to formulate or manufacture as a tablet that will still provide adequate or
full drug bioavailability.
4. Bitter testing drugs, drugs with an objectionable odor or drugs that are sensitive to
oxygen may require encapsulation or coating. In such cases, capsule may offer the best
and lowest cost.
2
7. General properties of Tablet dosage forms:
1. A tablet should have elegant product identity while free of defects like chips, cracks,
discoloration, and contamination.
2. Should have sufficient strength to withstand mechanical shock during its
production packaging, shipping and dispensing.
3. Should have the chemical and physical stability to maintain its physical attributes
over time
4. The tablet must be able to release the medicinal agents in a predictable and
reproducible manner.
5. Must have a chemical stability over time so as not to follow alteration of the
medicinal agents.
8. Different types of Tablets
(A) Tablets ingested orally:
1. Compressed tablet, e.g. Paracetamol tablet
2. Multiple compressed table
3. Delayed release tablet, e.g. Enteric coated Bisacodyl tablet
4. Sugar coated tablet, e.g. Multivitamin tablet
5. Film coated tablet, e.g. Metronidazole tablet
6. Chewable tablet, e.g. Antacid tablet
(B) Tablets used in oral cavity:
1. Buccal tablet, e.g. Vitamin-c tablet
2. Sublingual tablet, e.g. Vicks Menthol tablet
3. Troches or lozenges
4. Dental cone
9. (c) Tablets administered by other route:
1. Implantation tablet
2. Vaginal tablet, e.g. Clotrimazole tablet
(D) Tablets used to prepare solution:
1. Effervescent tablet, e.g. Dispirin tablet (Aspirin)
2. Dispensing tablet, e.g. Enzyme tablet (Digiplex)
3. Hypodermic tablet
4. Tablet triturates e.g. Enzyme tablet (Digiplex)
10. Types of tablets
Route of administration
– Oral tablets
– Sublingual or buccal tablets
– Vaginal tablets
Production process
– Compressed tablets
– Multiple compressed tablets
Tablet within a tablets: core and shell
Multilayer tablet
11. – Sugar coated tablets
Protect tablets from moisture
Mask odor and flavor
Elegance
– Film coated tablets
Thin film coat
Soluble or insoluble polymer film
12. – Chewable tablets
Rapid disintegrate
Antacid, flatulance: rapid action
Children drug
– Effervescent tablets
Dissolve in the water before drink
13. Tablet Ingredients
In addition to active ingredients, tablet contains a number of inert materials
known as additives or excipients. Different excipients are:
1. Diluent
2. Binder and adhesive
3. Disintegrents
4. Lubricants and glidants
5. Colouring agents
6. Flavoring agents
7. Sweetening agents
14. 1. Diluent: Diluents are fillers used to make required bulk of the tablet when the drug
dosage itself is inadequate to produce the bulk. Secondary reason is to provide better
tablet properties such as improve cohesion, to permit use of direct compression
manufacturing or to promote flow. A diluent should have following properties:
1. They must be non toxic
2. They must be commercially available in acceptable grade
3. There cost must be low
4. They must be physiologically inert
5. They must be physically & chemically stable by themselves & in combination
with the drugs.
6. They must be free from all microbial contamination.
7. They do not alter the bioavailability of drug.
8. They must be color compatible.
16. 2. Binders and Adhesives: These materials are added either dry or in
wet- form to form granules or to form cohesive compacts for directly
compressed tablet.
Example: Acacia, tragacanth- Solution for 10-25% Conc.
Cellulose derivatives- Methyl cellulose, Hydroxy propyl methyl
cellulose, Hydroxy propyl cellulose
Gelatin- 10-20% solution
Glucose- 50% solution
Polyvinylpyrrolidone (PVP)- 2% conc.
Starch paste-10-20% solution
Sodium alginate
Sorbitol
17. 3-Disintegrants: Added to a tablet formulation to
facilitate its breaking or disintegration when it contact in
water in the GIT.
Example: Starch- 5-20% of tablet weight.
Starch derivative – Primogel and Explotab (1-8%)
Clays- Veegum HV, bentonite 10% level in colored tablet only
Cellulose
Cellulose derivatives- Ac- Di-Sol (sodium carboxy methyl
cellulose)
Alginate
PVP (Polyvinylpyrrolidone), cross-linked
18. Superdisintegrants: Swells up to ten fold within 30
seconds when contact water.
Example: Crosscarmellose- cross-linked cellulose,
Crosspovidone- cross-linked povidone (polymer), Sodium
starch glycolate- cross-linked starch. These cross-linked
products swell upto 10n fold with in 30 seconds when in
contact with water.
A portion of disintegrant is added before granulation and a
portion before compression, which serve as glidants or
lubricant. Evaluation of carbon dioxide in effervescent
tablets is also one way of disintegration
19. 4. Lubricant and Glidants: Lubricants are intended to
prevent adhesion of the tablet materials to the surface of
dies and punches, reduce inter particle friction and may
improve the rate of flowof the tablet granulation.
Glidants are intended to promote flow of granules or powder
material by reducing the friction between the particles.
Example: Lubricants- Stearic acid, Stearic acid salt - Stearic acid,
Magnesium stearate, Talc, PEG (Polyethylene glycols),
Surfactants
Glidants- Corn Starch – 5-10% conc., Talc-5% conc., Silica
derivative - Colloidal silicas such as Cab-O-Sil, Syloid, Aerosil in
0.25-3% conc.
20. 5. Coloring agent: The use of colors and dyes in a tablet has three purposes:
(1) Masking of off color drugs
(2) Product Identification
(3) Production of more elegant product
All coloring agents must be approved and certified by FDA. Two forms of colors are
used in tablet preparation – FD &C and D & C dyes. These dyes are applied as
solution in the granulating agent or Lake form of these dyes. Lakes are dyes absorbed
on hydrous oxide and employed as dry powder coloring.
Example: FD & C yellow 6-sunset yellow
FD & C yellow 5- Tartrazine
FD & C green 3- Fast Green
FD & C blue 1- Brilliant Blue
FD & C blue 2 - Indigo carmine
D & C red 3- Erythrosine.
D & C red 22 – Eosin Y
21. 6. Flavoring agents: For chewable tablet- flavor oil are used
7. Sweetening agents: For chewable tablets: Sugar, mannitol.
Saccharine (artificial): 500 time’s sweeter than sucrose
Disadvantage: Bitter aftertaste and carcinogenic
Aspartame (artificial)
Disadvantage: Lack of stability in presence of moisture.
22. GRANULATION
Granulation is the process in which primary powder particles are made to
adhere to form larger, multi particle entities called granules.
Pharmaceutical granules typically have a size range between 0.2 and 4.0
mm.
Granules are used in the production of tablets or capsules.
Granules in such cases are made as an intermediate product and have a
typical size range between 0.2 and 0.5 mm.
23. Reasons for Granulation
To prevent segregation of the constituents of the powder mix.
– Segregation (or demixing) is due primarily to differences in the size or
density of the components of the mix.
– The smaller and/or denser particles concentrating at the base of a
container
– The larger and/or less dense ones above them.
– An ideal granulation will contain all the constituents of the mix in the
correct proportion in each granule and segregation of the ingredients
will not occur
25. Reasons for Granulation
To improve the flow properties of the mix
– Many powders, because of their small size, irregular
shape or surface characteristics, are cohesive and do not
flow well.
– Poor flow will often result in a wide weight variation
within the final product owing to variable fill of tablet
dies etc
26. Reasons for Granulation
To improve the compaction characteristics of the mix
– Some powders are difficult to compact even if a readily compactable
adhesive is included in the mix and some are compacted easily.
– This is associated with the distribution of the adhesive within the granule
and is a function of the method employed to produce the granule.
– Solute migration occurring during the postgranulation drying stage
results in a binder-rich outer layer to the granules.
– This in turn leads to direct binder–binder bonding, which assists the
consolidation of weakly bonding materials.
27. Other Reasons
The granulation of toxic materials will reduce the hazard
associated with the generation of toxic dust that may arise when
handling powders.
Materials which are slightly hygroscopic may adhere and form a
cake if stored as a powder. Granulation may reduce this hazard, as
the granules will be able to absorb some moisture and retain their
flow ability because of their size.
Granules, being denser than the parent powder mix, occupy less
volume per unit weight. They are therefore more convenient for
storage
29. Evaluation of Tablet
1. General Appearance: The general appearance of a tablet, its identity and
general elegance is essential for consumer acceptance, for control of lot-to-lot
uniformity and tablet-to-tablet uniformity. The control of general appearance
involves the measurement of size, shape, color, presence or absence of odor, taste
etc.
2. Size & Shape: It can be dimensionally described & controlled. The thickness of
a tablet is only variables. Tablet thickness can be measured by micrometer or by
other device. Tablet thickness should be controlled within a ± 5% variation of
standard value.
3. Unique identification marking: These marking utilize some form of
embossing, engraving or printing. These markings include company name or
symbol, product code, product name etc.
4. Organoleptic properties: Color distribution must be uniform with no
mottling. For visual color comparison compare the color of sample against
standard color.
5. Hardness and Friability: Tablet requires a certain amount of strength or
hardness and resistance to friability to withstand mechanical shakes of handling
in manufacture, packaging and shipping. Hardness generally measures the tablet
crushing strength
30. 6.Friability: Friability of a tablet can determine in laboratory by Roche friabilator.
This consist of a plastic chamber that revolves at 25 rpm, dropping the tablets
through a Distance of six inches in the friabilator, which is then operate for 100
revolutions. The tablets are reweighed. Compress tablet that lose less than 0.5 to 1.0
% of the Tablet weigh are consider acceptable.
31. 2. Drug Content and Release:
(I) Weight Variation test (U.S.P.): Take 20 tablet and weighed individually. Calculate
average weight and compare the individual tablet weight to the average. The tablet pass the
U.S.P. test if no more that 2 tablets are outside the percentage limit and if no tablet differs by
more than 2 times the percentage limit.
(II) Content Uniformity Test: Randomly select 30 tablets. 10 of these assayed individually.
The Tablet pass the test if 9 of the 10 tablets must contain not less than 85% and not more than
115% of the labeled drug content and the 10th tablet may not contain less than 75% and more
than 125% of the labeled content. If these conditions are not met, remaining 20 tablet assayed
individually and none may fall out side of the 85 to 115% range.
(III) Disintegration Test (U.S.P.): The U.S.P. device to test disintegration uses 6 glass
tubes that are 3” long; open at the top and 10 mesh screen at the bottom end. To test for
disintegration time, one tablet is placed in each tube and the basket rack is positioned in a 1-L
beaker of water, simulated gastric fluid or simulated intestinal fluid at 37 ± 20 C such that the
tablet remain 2.5 cm below the surface of liquid on their upward movement and not closer than
2.5 cm from the bottom of the beaker in their downward movement. Move the basket
containing the tablets up and down through a distance of 5-6 cm at a frequency of 28 to 32
cycles per minute. Floating of the tablets can be prevented by placing perforated plastic discs on
each tablet.
According to the test the tablet must disintegrate and all particles must pass through the 10
mesh screen in the time specified. If any residue remains, it must have a soft mass.
Disintegration time: Uncoated tablet: 5-30 minutes
Coated tablet: 1-2 hours
34. Direct compression
Tablets are compressed directly from powder blends
of the active ingredient and suitable excipients
No pretreatment of the powder blends by wet or dry
granulation procedures is necessary
Advantages
– Economy
Machine: fewer manufacturing steps and pieces of
equipment
35. Direct compression
Advantages
Elimination of granulation process
Heat (wet granulation)
Moisture (wet granulation)
High pressure (dry granulation)
Processing without the need for moisture and heat which is inherent
in most wet granulation procedures
Avoidance of high compaction pressures involves in producing
tablets by slugging or roll compaction
Elimination of variabilities in wet granulation processing
Binders (temp, viscous, age)
Viscosity of the granulating solution (depend on its temp),
How long it has been prepared,
36. Direct compression
Advantages
Rate of binder addition and kneading can affect the properties of the
granules formed
The granulating solution, the type and length of mixing and the
method and rate of wet and dry screening can change the density
and particle size of the granules, which can have a major effect on
fill weight and compaction qualities
Type and rate of drying
can lead not only to critical changes in equilibrium MC but also to unblending
as soluble active ingredients migrate to the surfaces of the drying granules
More unit processes are incorporated in production, the chances of
batch-to-batch variation are compounded
37. Direct compression
Advantages
– Prime particle dissociation
Each primary drug particle is liberated from the
tablet mass and is available for dissolution
Disintegrate rapidly to the primary particle state
– Uniformity of particle size
– Greater stability of tablet on aging
Color
Dissolution rate
38. Direct compression
Concerns
Excipient available from only one supplier and often cost more
than filler used in granulation
Procedure conservation
Machine investments
Lack of material knowledge
Physical limitation of drug
No compressibility
No flow ability
39. Flow properties
Angle of repose: tanθ=2h/D
Type of flow
<25 Excellent
25-30 Good
30-40 Passable
>40 Very poor
40. Some Important Aspects
low Humidity for Effervescent tablets & moisture sensitive drugs.
Pressure within areas like mixing & tableting area should remain on
negative side than central corridor
All areas should be free from dust & floating particles , if possible air
conditioned.
In coating section suitable exhaust systems
There should be properly organized & working air handling system to
supply purified air.
41. Temp control & Air control should be such that
there should be comfortable working
environment.
And no impact on characteristics of in-process
materials such as granulations, raw materials.
All areas should be properly ventilated.
42. PACKAGING AREA
Strip or Blister packaging
Machine.
Tablet counter
Leak tester
Air conditioning & Dehumidification equipment
43. References
Pharmaceutics. The science of dosage forms design.
(M.E. Aulton)
The theory and practice of industrial pharmacy.
Pharmaceutical dosage forms : Tablets. Volume 2.
Pharmaceutical dosage forms and drug delivery
systems.